NL7200327A - - Google Patents

Info

Publication number
NL7200327A
NL7200327A NL7200327A NL7200327A NL7200327A NL 7200327 A NL7200327 A NL 7200327A NL 7200327 A NL7200327 A NL 7200327A NL 7200327 A NL7200327 A NL 7200327A NL 7200327 A NL7200327 A NL 7200327A
Authority
NL
Netherlands
Application number
NL7200327A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7200327A publication Critical patent/NL7200327A/xx

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16F—SPRINGS; SHOCK-ABSORBERS; MEANS FOR DAMPING VIBRATION
    • F16F1/00—Springs
    • F16F1/36—Springs made of rubber or other material having high internal friction, e.g. thermoplastic elastomers
    • F16F1/40—Springs made of rubber or other material having high internal friction, e.g. thermoplastic elastomers consisting of a stack of similar elements separated by non-elastic intermediate layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Architecture (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7200327A 1971-01-29 1972-01-10 NL7200327A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2104179A DE2104179C3 (de) 1971-01-29 1971-01-29 exo-2-Phenyl-bicyclo- [2,2,1] -heptan-2- (N-methylpiperidol-4)-carbonsäureester und dessen Salze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
NL7200327A true NL7200327A (ja) 1972-08-01

Family

ID=5797265

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7200327A NL7200327A (ja) 1971-01-29 1972-01-10

Country Status (10)

Country Link
JP (2) JPS5744669B1 (ja)
AT (2) AT313279B (ja)
BE (1) BE777042A (ja)
CA (1) CA977758A (ja)
CH (1) CH574410A5 (ja)
DE (1) DE2104179C3 (ja)
FR (1) FR2123519B1 (ja)
GB (1) GB1320069A (ja)
NL (1) NL7200327A (ja)
YU (1) YU34677B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6110078A (ja) * 1984-06-26 1986-01-17 品川白煉瓦株式会社 溶鋼取鍋のライニング構造
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
CN102089304A (zh) 2008-05-13 2011-06-08 阿斯利康(瑞典)有限公司 作为m3毒蕈碱性受体拮抗剂的奎宁环衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99113C (ja) * 1956-06-16

Also Published As

Publication number Publication date
DE2104179A1 (de) 1972-08-10
DE2104179B2 (de) 1980-02-07
YU34677B (en) 1979-12-31
JPS5745430B2 (ja) 1982-09-28
JPS5775970A (en) 1982-05-12
DE2104179C3 (de) 1980-10-02
AT313278B (de) 1974-02-11
FR2123519A1 (ja) 1972-09-08
YU15872A (en) 1979-07-10
FR2123519B1 (ja) 1975-08-01
CA977758A (en) 1975-11-11
BE777042A (fr) 1972-06-21
AT313279B (de) 1974-02-11
CH574410A5 (ja) 1976-04-15
JPS5744669B1 (ja) 1982-09-22
GB1320069A (en) 1973-06-13

Similar Documents

Publication Publication Date Title
ATA136472A (ja)
JPS47511U (ja)
AR196074A1 (ja)
FR2123519B1 (ja)
AU3005371A (ja)
AU2952271A (ja)
AU2485671A (ja)
AU2941471A (ja)
AU2894671A (ja)
AU2684071A (ja)
AU2415871A (ja)
AU2930871A (ja)
AU2907471A (ja)
AU3038671A (ja)
AU2455871A (ja)
AU2456871A (ja)
AU2399971A (ja)
AU2927871A (ja)
AU2473671A (ja)
AU2503871A (ja)
AU2938071A (ja)
AU2684171A (ja)
AU2940971A (ja)
AU1109576A (ja)
AR202997Q (ja)

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed